| Today, Wed, Nov 25, 2009 | | • | 7 All-Star Stocks to Make Your Portfolio Shine
at Motley Fool (Wed 11:38am)
| | • | GlaxoSmithKline Seeks to Commercialize Viread in China for Hepatitis B
at Seeking Alpha (Wed 7:11am)
| | Tue, Nov 24, 2009 | | • | Gilead Sciences to Present at the NASDAQ OMX 23rd Investor Program
Business Wire (Tue 4:30pm)
| | • | Gilead in Asian deal for hepatitis B drug
at bizjournals.com (Tue 10:05am)
| | • | Gilead signs sales deal with Glaxo for Viread
AP (Tue 9:54am)
| | • | UPDATE - WHO probing drug resistant swine flu
at Reuters (Tue 9:36am)
| | • | Gilead and GlaxoSmithKline Announce Agreement to Commercialize Viread® for Chronic Hepatitis B in Key Asian Countries
Business Wire (Tue 9:00am)
| | • | [video] Healthcare Stocks: Safe and Speculative
TheStreet.com TV (Tue 8:30am)
| | Mon, Nov 23, 2009 | | • | [video] Healthcare Stocks: Safe and Speculative
at TheStreet.com (Mon, Nov 23)
| | • | Former CIO Of Duff And Phelps Reveals Top Stock Picks In His Current Institutional Portfolio
Wall Street Transcript (Mon, Nov 23)
| | Sun, Nov 22, 2009 | | • | The Highest Possible Returns. Period.
at Motley Fool (Sun, Nov 22)
| | Fri, Nov 20, 2009 | | • | UPDATE - UK investigates spread of drug resistant swine flu
at Reuters (Fri, Nov 20)
| | • | J&J stays true to its diversified model
at FT.com (Fri, Nov 20)
| | Thu, Nov 19, 2009 | | • | Ten Minutes That Mattered: Gilead's Martin
at Forbes.com (Thu, Nov 19)
| | • | 5 Stocks Geared for Growth
at Motley Fool (Thu, Nov 19)
| | • | Now's a Great Time to Invest -- So Don't Blow It Like This
at Motley Fool (Thu, Nov 19)
| | Wed, Nov 18, 2009 | | • | 5 Stocks Making Cash
at Motley Fool (Wed, Nov 18)
| | • | Connor Browne: Asset Allocation Is Key in Current Environment
at Seeking Alpha (Wed, Nov 18)
| | Tue, Nov 17, 2009 | | • | A Big Upgrade for Sanofi-Aventis
at Motley Fool (Tue, Nov 17)
| | Mon, Nov 16, 2009 | | • | The Worst Stocks to Buy Today
at Motley Fool (Mon, Nov 16)
|
Add GILD News to My Yahoo!:
 
| |
|
0.23% Nasdaq 
0.17 (0.36%) 
Headlines
